AOD-9604 peptide injections may be incorporated into wellness programs designed to support metabolism, fat utilization, and weight management
GLP-1 (Glucagon-Like Peptide-1) medications, such as semaglutide and trizepatide, are a class of drugs that have gained significant attention for their ability to promote weight loss
Glutathiones ability to neutralise these ROS has led to it often being referred to as the master antioxidant
The news also went viral on social media, with a variety of commentators dissecting the details.
In addition, other GLP-1RAs, such as Beinaglutide, Supaglutide, Emaglutide, and Efpeglenatide, are currently in clinical trials
In the SURPASS clinical trial program for type 2 diabetes, patients achieved HbA1c reductions of 1.9% to 2.6% depending on dose, with weight loss averaging 15-22 pounds across studies